We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Positive Interim Phase 1 Data for mRNA Vaccine Against SARS-CoV-2

Product News   May 19, 2020

 
Positive Interim Phase 1 Data for mRNA Vaccine Against SARS-CoV-2
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

IRBM’s Advent Manufactures 13,000 Doses of COVID-19 Vaccine for Use in Phase 2/3 Clinical Trials

Product News

Advent has manufactured 13,000 doses of the novel COVID-19 vaccine candidate, ChAdOx1 nCoV-19 (now known as AZD1222) for use in the Phase 2/3 clinical trial COV002 by the University of Oxford.

READ MORE

New High-Resolution Mass Spectrometer Redefines Unknown Small Molecule and Peptide Mapping Applications

Product News

Thermo Fisher Scientific’s newest Orbitrap high-resolution mass spectrometer is designed to deliver proven measurement capabilities in a system developed for increased productivity.

READ MORE

Next-Generation Analytical Software Strengthens Data Exploration

Product News

Scientists in the life sciences can now benefit from upgrades to a suite of analytical software solutions with new features designed to enhance productivity, confidence and accuracy in numerous fields.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE